| 1426 |
National Cancer Institute |
Html |
en |
Childhood Ependymoma Treatment (PDQ®)–Health Professional Version |
In childhood ependymoma, cancer forms in the tissues of the brain and spinal cord. The cause of ependymoma is unknown. Find out about the molecular and clinical features, diagnosis, prognosis, treatment, and clinical trials for pediatric ependymoma, subependymoma, myxopapillary ependymoma, anaplastic ependymoma, and RELA fusion–positive ependymoma. |
| childhood recurrent ependymoma | 0.446141 |
| Merchant TE | 0.374501 |
| Brain Tumor Registry | 0.351132 |
| childhood brain tumor | 0.35242 |
| spinal cord ependymomas | 0.479172 |
| nervous system ependymoma | 0.395153 |
| posterior fossa ependymoma | 0.628195 |
| brain tumors | 0.516421 |
| children | 0.409198 |
| malignant brain tumors | 0.384396 |
| newly diagnosed ependymoma | 0.411931 |
| Sayegh ET | 0.377382 |
| Int J Radiat | 0.476989 |
| Radiat Oncol Biol | 0.6983 |
| World Health Organization | 0.41477 |
| intracranial ependymoma recurrence | 0.508211 |
| pediatric supratentorial tumors | 0.369961 |
| posterior fossa tumors | 0.3562 |
| infratentorial ependymoma | 0.423041 |
| ependymoma patients | 0.42421 |
| intracranial ependymomas | 0.39986 |
| Supratentorial ependymoma | 0.435338 |
| Clin Cancer Res | 0.386576 |
| paediatric ependymoma | 0.450128 |
| pediatric intracranial ependymoma | 0.570833 |
|
| radiation therapy | 0.449829 |
| Acta Neuropathol | 0.35243 |
| et al. | 0.743726 |
| childhood ependymoma | 0.513088 |
| intracranial ependymoma | 0.927373 |
| recurrent ependymoma | 0.45402 |
| Neuro Oncol | 0.356088 |
| primary brain tumors | 0.39985 |
| pediatric intracranial ependymomas | 0.371298 |
| adult ependymoma cases | 0.44321 |
| Pediatr Blood Cancer | 0.534048 |
| childhood ependymomas | 0.358916 |
| Metastatic ependymoma | 0.401089 |
| posterior fossa ependymomas | 0.381573 |
| spinal cord | 0.504643 |
| Abstract | 0.696 |
| non-anaplastic ependymoma | 0.396839 |
| childhood intracranial ependymoma | 0.687299 |
| Clin Oncol | 0.484182 |
| childhood brain tumors | 0.3515 |
| Oncol Biol Phys | 0.714533 |
| spinal canal ependymoma | 0.421296 |
| Central Brain Tumor | 0.351707 |
| Childs Nerv Syst | 0.489135 |
|
CLICK HERE |
| 1560 |
National Cancer Institute |
Html |
en |
Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of bile duct cancer. |
| cancer treatment | 0.353124 |
| bile ducts | 0.564994 |
| bile duct cancer | 0.93969 |
| body | 0.371618 |
| Recurrent bile duct | 0.466297 |
| extrahepatic bile duct | 0.483916 |
| PDQ cancer information | 0.368 |
| resectable perihilar bile | 0.374861 |
| perihilar bile duct | 0.569945 |
| clinical trial search | 0.384576 |
| bile duct | 0.961515 |
| clinical trials | 0.565197 |
| nearby lymph nodes | 0.369687 |
| cancer information summary | 0.357079 |
| resectable bile duct | 0.431592 |
| bile duct cancers | 0.440742 |
| liver | 0.42559 |
| patients | 0.355382 |
| clinical trial | 0.45121 |
| distal extrahepatic bile | 0.464256 |
| radiation therapy | 0.471059 |
| small intestine | 0.398038 |
| intrahepatic bile duct | 0.502288 |
| treatment | 0.464058 |
| transhepatic biliary drainage | 0.355933 |
|
| NCI-supported cancer | 0.356212 |
| cancer cells | 0.412313 |
| bile duct wall | 0.415716 |
| stage bile duct | 0.454009 |
| metastatic perihilar bile | 0.377513 |
| common bile duct | 0.446017 |
| National Cancer Institute | 0.386156 |
| Stent placement | 0.359539 |
| metastatic bile duct | 0.439918 |
| new treatment | 0.359129 |
| common hepatic duct | 0.40199 |
| external radiation therapy | 0.3932 |
| carry bile | 0.373127 |
| procedure | 0.357714 |
| swollen bile ducts | 0.401928 |
| cystic duct | 0.364061 |
| cancer clinical trials | 0.390707 |
| duct cancer cells | 0.3797 |
| resectable intrahepatic bile | 0.377924 |
| tumor | 0.353722 |
| intrahepatic bile ducts | 0.394408 |
| internal radiation therapy | 0.382915 |
| metastatic intrahepatic bile | 0.380622 |
| information | 0.370053 |
|
CLICK HERE |
| 1631 |
National Cancer Institute |
Html |
en |
Merkel Cell Carcinoma Treatment (PDQ®)–Patient Version |
Merkel cell carcinoma is a rare disease in which cancer cells form in Merkel cells in the skin and starts most often in areas of skin exposed to the sun. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for Merkel cell carcinoma. |
| cancer treatment | 0.369679 |
| distant parts | 0.362908 |
| lymph node dissection | 0.588951 |
| body | 0.395316 |
| PDQ cancer information | 0.408963 |
| clinical trial search | 0.383573 |
| metastatic Merkel cell | 0.359176 |
| clinical trials | 0.614596 |
| nearby lymph nodes | 0.400683 |
| cancer information summary | 0.387551 |
| clinical trial | 0.501642 |
| Merkel cells | 0.371884 |
| tumor area | 0.368378 |
| patients | 0.364556 |
| lymph node biopsy | 0.419179 |
| sentinel lymph node | 0.455835 |
| radical lymph node | 0.418343 |
| Recurrent Merkel cell | 0.378899 |
| malignant tumor cells | 0.373594 |
| NCI PDQ cancer | 0.361276 |
| Treatment Option Overview | 0.361132 |
| lymph nodes | 0.564493 |
| radiation therapy | 0.43011 |
| Treatment Editorial Board | 0.360626 |
| general cancer information | 0.354614 |
|
| treatment | 0.462922 |
| wide local excision | 0.414099 |
| swollen lymph nodes | 0.431138 |
| NCI-supported cancer | 0.355921 |
| cancer cells | 0.429285 |
| Cancer Information Service | 0.355025 |
| treatment clinical trials | 0.372695 |
| National Cancer Institute | 0.42114 |
| Cell Carcinoma Treatment | 0.359564 |
| regional lymph node | 0.418618 |
| lymph vessels | 0.377608 |
| new treatment | 0.401967 |
| merkel cell carcinoma | 0.969094 |
| primary tumor | 0.368519 |
| cancer clinical trials | 0.393874 |
| stage | 0.380167 |
| cell lung cancer | 0.358436 |
| tumor | 0.434689 |
| comprehensive cancer information | 0.354073 |
| cancer | 0.71533 |
| information | 0.409547 |
| lymph ducts | 0.372558 |
| standard treatment | 0.354595 |
| physical exam | 0.362972 |
|
CLICK HERE |
| 1744 |
National Cancer Institute |
Html |
en |
Fluoridated Water |
A fact sheet that reviews research about the possibility of a connection between fluoridated water and cancer. |
| human epidemiologic data | 0.594773 |
| Health Service report | 0.593262 |
| fluoride | 0.975933 |
| naturally occurring element | 0.597937 |
| Water Fluoridation Statistics | 0.623696 |
| current fluoridated water | 0.628477 |
| Disease Control | 0.669272 |
| detectable cancer risk | 0.614332 |
| human epidemiologic studies | 0.60115 |
| human epidemiologic | 0.621471 |
| community water fluoridation | 0.640412 |
| recent population-based studies | 0.592374 |
| public drinking water | 0.647792 |
| fluoridated drinking water | 0.666776 |
| cumulative fluoride exposure | 0.764553 |
| drinking water quality | 0.646469 |
| sodium fluoride | 0.715451 |
| Ingested Fluoride | 0.834058 |
| water fluoridation | 0.705423 |
| fluoride concentration | 0.727809 |
| fewer dental caries | 0.600428 |
| cancer case records | 0.605334 |
| water cause cancer | 0.645853 |
| fluoride benefits | 0.721837 |
| drinking water supplies | 0.676312 |
|
| Health Effects | 0.629934 |
| fluoride exposure | 0.797986 |
| bone tumors | 0.594815 |
| United States | 0.643827 |
| cancer registry data | 0.601829 |
| National Toxicology Program | 0.663407 |
| Environmental Health Sciences | 0.59604 |
| fluoridated water | 0.77455 |
| water treatment records | 0.619812 |
| fluoride intake | 0.729368 |
| bone fluoride levels | 0.775983 |
| drinking water | 0.947407 |
| cancer death records | 0.605385 |
| Subsequent interview studies | 0.59194 |
| public water systems | 0.633935 |
| fluoride accumulates | 0.757179 |
| fluoride content | 0.748381 |
| tooth decay | 0.600449 |
| water supply | 0.612845 |
| National Research Council | 0.659684 |
| parts water | 0.59656 |
| Public Health Service | 0.66604 |
| cancer risk | 0.653999 |
| et al | 0.614927 |
|
CLICK HERE |
| 1924 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de nasofaringe (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de nasofaringe. |
| tratamiento.Ciertas formas | 0.524228 |
| glándula tiroides | 0.523181 |
| estadios iva | 0.528495 |
| Neck Cancer | 0.521392 |
| siguientes procedimientos | 0.7107 |
| estadio ii | 0.666414 |
| rayos x | 0.537811 |
| pequeñas marcas | 0.522053 |
| enlace drugs approved | 0.539586 |
| National Cancer Institute | 0.517706 |
| siguientes riesgos | 0.513715 |
| Instituto Nacional | 0.534665 |
|
| malla ayuda | 0.523662 |
| hormonas tiroideas | 0.523525 |
| PDQ Tratamiento | 0.533313 |
| ganglios linfáticos detrás | 0.99863 |
| Physician Data Query | 0.572904 |
| estadio iii | 0.585657 |
| espacio parafarÃngeo | 0.772191 |
| cáncer.ampliar radioterapia | 0.583477 |
| glándula tiroidea | 0.524738 |
| Estadio IVC | 0.548072 |
| Estadio IVA | 0.547554 |
| siguientes estadios | 0.604168 |
|
CLICK HERE |
| 1977 |
National Cancer Institute |
Html |
es |
Tratamiento del carcinoma de corteza suprarrenal (PDQ®)–Versión para pacientes |
Resumen de revisión revisada por expertos acerca del tratamiento del carcinoma de corteza suprarrenal. |
| siguientes procedimientos | 0.496457 |
| tinte circula | 0.500083 |
| pequeña cantidad | 0.426407 |
| estadio ii | 0.722852 |
| vÃa oral | 0.42258 |
| rayos x | 0.485722 |
| ondas sonoras | 0.428325 |
| National Cancer Institute | 0.418399 |
| sustancia llamada gadolinio | 0.451231 |
| suprarrenal elabora hormonas | 0.951617 |
| siguientes riesgos | 0.416128 |
| secciones cáncer | 0.564083 |
| Instituto Nacional | 0.51582 |
| PDQ Tratamiento | 0.443801 |
| siguientes hormonas | 0.456613 |
|
| presente sección | 0.419609 |
| corteza suprarrenal causa | 0.829807 |
| siguientes funciones | 0.454626 |
| Physician Data Query | 0.471125 |
| médula suprarrenal.Ampliar | 0.44071 |
| estadio iii | 0.71977 |
| caracterÃsticas masculinas | 0.438548 |
| siguientes enfermedades | 0.449744 |
| PDQ Feocromocitoma | 0.493816 |
| suprarrenal causa efectos | 0.739636 |
| siguientes terapias | 0.423482 |
| PDQ Cánceres | 0.484481 |
| siguientes enlaces | 0.420507 |
| suprarrenal funcionante elabora | 0.710246 |
| siguientes pruebas | 0.503631 |
|
CLICK HERE |
| 1994 |
National Cancer Institute |
Html |
es |
Tratamiento del craneofaringioma infantil (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del craneofaringioma infantil |
| childhood-onset craniopharyngioma | 0.555421 |
| Winkfield KM | 0.461372 |
| Merchant TE | 0.538632 |
| Pediatric Patients with | 0.460492 |
| largo plazo | 0.456579 |
| brain tumors | 0.465364 |
| cystic craniopharyngiomas | 0.546839 |
| pediatric craniopharyngiomas with | 0.478389 |
| after childhood-onset craniopharyngioma | 0.509117 |
| calcificación quizás | 0.453393 |
| craneofaringioma infantil grupo | 0.448145 |
| past treatment modalities | 0.44452 |
| Instituto Nacional | 0.469284 |
| Proton beam therapy | 0.44785 |
| proton radiotherapy | 0.445521 |
| Radiat Oncol Biol | 0.691179 |
| Pediatric Brain Tumor | 0.463199 |
| Endocrinol Metab | 0.525086 |
| Gebhardt U | 0.460882 |
| central nervous system | 0.452583 |
| proton therapy | 0.48171 |
| tumor control | 0.4621 |
| Optimal treatment strategy | 0.445937 |
| radiation therapy | 0.847388 |
| Clin Endocrinol Metab | 0.477641 |
|
| following treatment | 0.481728 |
| subtotal quizás | 0.449448 |
| Neurosurg Focus | 0.603105 |
| Pediatric MATCH | 0.494065 |
| pediatric craniopharyngioma | 0.961568 |
| tumores quÃsticos recidivantes | 0.450542 |
| PDQ Descripción | 0.449293 |
| Pediatr Blood Cancer | 0.611837 |
| after radiation therapy | 0.60095 |
| With Craniopharyngioma That | 0.51489 |
| efectos tardÃos | 0.785518 |
| PDQ Efectos tardÃos | 0.471103 |
| tumor control with | 0.459757 |
| Neurosurgical treatment | 0.478026 |
| National Cancer Institute | 0.453747 |
| with proton radiotherapy | 0.445448 |
| tumor quizás | 0.486067 |
| PDQ Tratamiento | 0.463786 |
| treatment strategy | 0.478645 |
| long-term results | 0.483149 |
| Oncol Biol Phys | 0.703438 |
| Neurosurg Pediatr | 0.66815 |
| long-term gh therapy | 0.447185 |
| patients with craniopharyngioma | 0.738686 |
|
CLICK HERE |
| 2988 |
National Cancer Institute |
Html |
en |
Secondhand Smoke |
Smoking affects both you and your loved one's health. Learn about the consequences of secondhand smoke and how you can protect your family. |
| feet | 0.409991 |
| dangers | 0.420271 |
| Lung cancer | 0.428942 |
| good example | 0.428021 |
| non-smoker | 0.407426 |
| care staff | 0.426607 |
| nicotine affect | 0.427281 |
| babysitters | 0.406286 |
| body | 0.411562 |
| smoker | 0.414092 |
| children | 0.431937 |
| harms | 0.407652 |
| sure caretakers | 0.428123 |
| secondhand smoke | 0.971613 |
| non-smokers | 0.43912 |
| heart disease‚ | 0.429635 |
| Fact | 0.410452 |
| short time | 0.429909 |
| somebody | 0.406088 |
| health problems | 0.428728 |
| smokefree restaurants | 0.432863 |
| lung infections | 0.428228 |
| smoking indoors | 0.445671 |
| main way smoking | 0.477206 |
| Breathing problems | 0.428866 |
|
| indoor public places | 0.450365 |
| babies | 0.424287 |
| smokers | 0.419121 |
| air | 0.417572 |
| life | 0.412446 |
| Breathing secondhand smoke | 0.5983 |
| infant death syndrome | 0.453829 |
| smoking | 0.508887 |
| National Cancer Institute | 0.448359 |
| heart attack‚ | 0.429618 |
| kids | 0.411336 |
| quiz | 0.411311 |
| cigarette | 0.405834 |
| coughing‚ extra phlegm‚ | 0.454984 |
| bronchitis | 0.405901 |
| people | 0.432125 |
| home | 0.416331 |
| nannies | 0.405803 |
| severe attacks | 0.428972 |
| best thing | 0.428251 |
| shortness | 0.406847 |
| ear infections | 0.428442 |
| low birth weight | 0.454001 |
| family | 0.425482 |
|
CLICK HERE |
| 15485 |
National Cancer Institute |
Html |
null |
NCI-Related Cancer Moonshot Activities |
This page describes a number of activities NCI is involved in that support the goals of the Cancer Moonshot. |
|
|
CLICK HERE |
| 16682 |
National Cancer Institute |
Html |
es |
714-X (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos sobre el uso del 714-X como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta. |
| suficiente información | 0.416844 |
| 714-X ayuda | 0.603181 |
| Centro Nacional | 0.441981 |
| New Hampshire Avenue | 0.428509 |
| Drug Administration | 0.417778 |
| NCI Best Case | 0.453667 |
| historial médico | 0.42385 |
| datos bibliográficos pubmed | 0.43091 |
| siguientes preguntas | 0.416986 |
| siguientes riesgos | 0.421888 |
| seguro médico | 0.417314 |
| Instituto Nacional | 0.654 |
| vitamina e | 0.42491 |
|
| Salud Complementaria | 0.462517 |
| Visuals Online | 0.421729 |
| complementarias revisa | 0.430487 |
| Physician Data Query | 0.526604 |
| Estados Unidos | 0.798049 |
| libre uso | 0.424103 |
| página manejo | 0.420327 |
| ¿El tratamiento | 0.432404 |
| ¿Los beneficios | 0.418313 |
| juntos cam | 0.417388 |
| siguientes formas | 0.425809 |
| Series Program | 0.418184 |
| medicina complementaria | 0.936374 |
|
CLICK HERE |